Peter Robinson

Associate Director - Global Transfer Pricing Policy & Strategy at ASTRAZENECA

Peter has over 12 years' experience working in transfer pricing. This includes working as a consultant advising businesses operating across different industries and also as an in-house professional at AstraZeneca plc in the life sciences industry. His experience includes working with various tax authorities across a wide range of transfer pricing controversy matters including negotiating bilateral APAs, MAP claims and resolving tax audits. Peter can offer insights on how AI is poised to influence, and potentially transform, the relationship between taxpayers and tax authorities as the landscape evolves.